Protalix BioTherapeutics (PLX) Misses Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts PLX Hot Sheet
Price: $2.75 +2.23%
EPS Growth %: -266.7%
Financial Fact:
NET LOSS FOR THE PERIOD: -7.29M
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: -266.7%
Financial Fact:
NET LOSS FOR THE PERIOD: -7.29M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Protalix BioTherapeutics (NYSE: PLX) reported Q2 EPS of ($0.03). Revenue for the quarter came in at $13.47 million.
For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GameStop CEO Cohen buys 1.15M shares
- Vicor raises Q3 2026 revenue guidance on new licensing deal
- Paramount Skydance extends debt offer deadlines to October 2
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
